pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 17·1 min read
save

Conflicting guidelines leave women unsure when to start routine mammograms

May 17, 2026·read at STAT ↗Neutral

Deciding when to begin routine mammograms is confusing because major health groups recommend different starting ages-some say 40, others 45, and a recent recommendation pushes the start to 50. They also disagree on whether screening should be done yearly or every other year.

The guidelines are aimed at women at average risk and without symptoms, but defining "average" risk is difficult given how common breast cancer is. This makes it hard for individuals to weigh the benefits and drawbacks of early screening.

Dr. Laura Esserman of the University of California, San Francisco noted that breast cancer is not a single disease, so a one‑size‑fits‑all screening approach may not be appropriate. She is leading research to better identify low, high, and intermediate risk groups to eventually provide more personalized screening recommendations.

More than 320,000 women in the United States are expected to be diagnosed with breast cancer this year, according to the American Cancer Society. While death rates have been falling for decades thanks to improved treatments, breast cancer remains the second‑most common cause of cancer death among U.S. women, and new diagnoses are slowly increasing.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “When should you get a mammogram? Conflicting advice makes it hard to know”

read at STAT ↗
1,181 words · retrieved May 17
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2
topics
Oncology35Breast Cancer15Diagnostics CompanyPain

related stories

  • 3d agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Oct 8The Nobel boys club (again)STAT
  • Oct 8Breast cancer can behave differently in older women. This physician is making more tailored treatments a realitySTAT
  • Sep 3Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readoutFierce Biotech
  • Aug 25Opinion: Cancer screening guidelines need to address long-term care facilitiesSTAT